QL1207H Injection

· Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QL1207H Injection, covering 2026-03-24 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of QL1207H Injection Versus Aflibercept for Neovascular Age-related Macular Degeneration [Phase 3]

See pricing